GlycoMimetics CEO Rachel King's 2019 pay slips 16% to $2.7M
GlycoMimetics reports 2019 executive compensation
By ExecPay News
Published: April 16, 2020
GlycoMimetics reported fiscal year 2019 executive compensation information on April 16, 2020.
In 2019, three executives at GlycoMimetics received on average a compensation package of $1.7M, a 10% decrease compared to previous year.
Average pay of disclosed executives at GlycoMimetics
Rachel K. King, Chief Executive Officer, received $2.7M in total, which decreased by 16% compared to 2018. 69% of King's compensation, or $1.8M, was in option awards. King also received $277K in non-equity incentive plan, $559K in salary, as well as $8.5K in other compensation.
Helen M. Thackray, Chief Medical Officer, received a compensation package of $1.3M, which decreased by 19% compared to previous year. 54% of the compensation package, or $696K, was in option awards.
John L. Magnani, Chief Scientific Officer, earned $1.3M in 2019, a 19% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 16, 2020.